EGFR mutated NSCLC exhibited reduced CD8+ lymphocyte infiltration, while KRAS mutant displayed higher CD8+ T cells, as detected using tissue microarray (58). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.